Vaccibody As Alpha and Beta Analysis
VACCDelisted Stock | USD 2.23 0.04 1.83% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Vaccibody As. It also helps investors analyze the systematic and unsystematic risks associated with investing in Vaccibody over a specified time horizon. Remember, high Vaccibody's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Vaccibody's market risk premium analysis include:
Beta (0.18) | Alpha (0.11) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Vaccibody |
Vaccibody Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Vaccibody market risk premium is the additional return an investor will receive from holding Vaccibody long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Vaccibody. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Vaccibody's performance over market.α | -0.11 | β | -0.18 |
Vaccibody Fundamentals Vs Peers
Comparing Vaccibody's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Vaccibody's direct or indirect competition across all of the common fundamentals between Vaccibody and the related equities. This way, we can detect undervalued stocks with similar characteristics as Vaccibody or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Vaccibody's fundamental indicators could also be used in its relative valuation, which is a method of valuing Vaccibody by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Vaccibody to competition |
Fundamentals | Vaccibody | Peer Average |
Return On Equity | -0.23 | -0.31 |
Return On Asset | -0.15 | -0.14 |
Operating Margin | (77.18) % | (5.51) % |
Current Valuation | 32.03 M | 16.62 B |
Shares Outstanding | 38.55 M | 571.82 M |
Shares Owned By Insiders | 3.45 % | 10.09 % |
Shares Owned By Institutions | 49.84 % | 39.21 % |
Vaccibody Opportunities
Vaccibody Return and Market Media
The Stock received a lot of media exposure during the period. Price Growth (%) |
Timeline |
About Vaccibody Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Vaccibody or other delisted stocks. Alpha measures the amount that position in Vaccibody As has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Vaccibody Upcoming Company Events
As portrayed in its financial statements, the presentation of Vaccibody's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Vaccibody's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Vaccibody's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Vaccibody. Please utilize our Beneish M Score to check the likelihood of Vaccibody's management manipulating its earnings.
9th of November 2023 Upcoming Quarterly Report | View | |
22nd of March 2024 Next Financial Report | View | |
30th of September 2023 Next Fiscal Quarter End | View | |
22nd of March 2024 Next Fiscal Year End | View | |
30th of June 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Vaccibody
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Vaccibody Stock
If you are still planning to invest in Vaccibody As check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaccibody's history and understand the potential risks before investing.
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |